Gilead Sciences Total Current Liabilities 2010-2025 | GILD

Gilead Sciences total current liabilities from 2010 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
  • Gilead Sciences total current liabilities for the quarter ending March 31, 2025 were $12.004B, a 6.42% increase year-over-year.
  • Gilead Sciences total current liabilities for 2024 were $12.004B, a 6.42% increase from 2023.
  • Gilead Sciences total current liabilities for 2023 were $11.28B, a 0.38% increase from 2022.
  • Gilead Sciences total current liabilities for 2022 were $11.237B, a 3.21% decline from 2021.
Gilead Sciences Annual Total Current Liabilities
(Millions of US $)
2024 $12,004
2023 $11,280
2022 $11,237
2021 $11,610
2020 $11,397
2019 $9,759
2018 $10,605
2017 $11,635
2016 $9,218
2015 $9,890
2014 $5,761
2013 $6,407
2012 $4,238
2011 $2,515
2010 $2,465
2009 $1,872
Gilead Sciences Quarterly Total Current Liabilities
(Millions of US $)
2024-12-31 $12,004
2024-09-30 $11,725
2024-06-30 $10,781
2024-03-31 $13,015
2023-12-31 $11,280
2023-09-30 $11,945
2023-06-30 $13,964
2023-03-31 $10,528
2022-12-31 $11,237
2022-09-30 $10,423
2022-06-30 $9,220
2022-03-31 $8,558
2021-12-31 $11,610
2021-09-30 $10,245
2021-06-30 $10,214
2021-03-31 $9,705
2020-12-31 $11,397
2020-09-30 $9,509
2020-06-30 $10,564
2020-03-31 $8,879
2019-12-31 $9,759
2019-09-30 $9,567
2019-06-30 $8,961
2019-03-31 $9,397
2018-12-31 $10,605
2018-09-30 $10,116
2018-06-30 $10,912
2018-03-31 $10,670
2017-12-31 $11,635
2017-09-30 $9,597
2017-06-30 $8,492
2017-03-31 $8,282
2016-12-31 $9,218
2016-09-30 $11,073
2016-06-30 $10,444
2016-03-31 $10,910
2015-12-31 $9,890
2015-09-30 $9,360
2015-06-30 $8,925
2015-03-31 $7,428
2014-12-31 $5,761
2014-09-30 $6,055
2014-06-30 $6,228
2014-03-31 $5,915
2013-12-31 $6,407
2013-09-30 $4,895
2013-06-30 $4,937
2013-03-31 $4,290
2012-12-31 $4,238
2012-09-30 $4,802
2012-06-30 $4,987
2012-03-31 $4,188
2011-12-31 $2,515
2011-09-30 $2,224
2011-06-30 $2,311
2011-03-31 $2,769
2010-12-31 $2,465
2010-09-30 $2,590
2010-06-30 $3,106
2010-03-31 $1,888
2009-12-31 $1,872
2009-09-30 $1,889
2009-06-30 $1,778
2009-03-31 $1,262
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $128.563B $28.754B
Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya, Odefsey, Descovy, Biktarvy and Truvada. The portfolio also includes hepatitis C virus drugs like Harvoni and Epclusa and HBV drug. The first cell therapy approved for the treatment of adult patients with relapsed or refractory large B-cell lymphoma, has diversified Gilead's portfolio. Tecartus, another CAR T-cell therapy, was granted an accelerated approval in the United States for the treatment of relapsed or refractory mantle cell lymphoma. The company is also working on diversifying and growing its business beyond antivirals into other therapeutic areas. Gilead is also making inroads in the oncology space with strategic collaborations and acquisitions.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) GB $218.669B 16.32
Amgen (AMGN) US $152.575B 13.67
Vertex Pharmaceuticals (VRTX) US $128.247B 0.00
Bristol Myers Squibb (BMY) US $100.960B 6.76
GSK (GSK) GB $79.950B 9.50
CSL (CSLLY) AU $77.958B 0.00
Regeneron Pharmaceuticals (REGN) US $64.502B 15.46
Argenex SE (ARGX) NL $39.072B 268.87
Alnylam Pharmaceuticals (ALNY) US $33.189B 0.00
BeiGene (ONC) KY $25.286B 0.00
BioNTech SE (BNTX) DE $24.580B 0.00
Biogen (BIIB) US $17.701B 7.64
Genmab (GNMSF) DK $13.552B 13.96
Genmab (GMAB) DK $13.420B 16.88
Insmed (INSM) US $13.207B 0.00
Illumina (ILMN) US $12.109B 31.23
Incyte (INCY) US $12.007B 91.22
BioMarin Pharmaceutical (BMRN) US $11.965B 19.54
Swedish Orphan Biovitrum (BIOVF) SE $10.913B 27.87
Exelixis (EXEL) US $10.717B 22.22
Moderna (MRNA) US $10.450B 0.00
Ascendis Pharma (ASND) DK $10.211B 0.00
QIAGEN (QGEN) NL $9.381B 18.88
Exact Sciences (EXAS) US $8.894B 0.00
Roivant Sciences (ROIV) GB $8.263B 0.00
Bio-Techne Corp (TECH) US $7.846B 30.08
Repligen (RGEN) US $7.704B 86.29
Revolution Medicines (RVMD) US $7.570B 0.00
Halozyme Therapeutics (HALO) US $7.416B 15.31
Jazz Pharmaceuticals (JAZZ) IE $7.222B 6.43
TG Therapeutics (TGTX) US $7.204B 324.07
Bio-Rad Laboratories (BIO.B) US $6.566B 22.20
Blueprint Medicines (BPMC) US $6.343B 0.00
Legend Biotech (LEGN) US $6.237B 0.00
Sarepta Therapeutics (SRPT) US $6.169B 28.67
Verona Pharma American Depositary Share (VRNA) GB $6.141B 0.00
Telix Pharmaceuticals (TLX) AU $6.062B 0.00
Guardant Health (GH) US $6.054B 0.00
ADMA Biologics Inc (ADMA) US $5.529B 46.54
Axsome Therapeutics (AXSM) US $5.524B 0.00
Nuvalent (NUVL) US $5.458B 0.00
Cytokinetics (CYTK) US $5.116B 0.00
Alkermes (ALKS) IE $5.041B 13.53
Zealand Pharma (ZLDPF) DK $4.995B 0.00
Krystal Biotech (KRYS) US $4.788B 49.91
Vaxcyte (PCVX) US $4.546B 0.00
Rhythm Pharmaceuticals (RYTM) US $4.058B 0.00
Avidity Biosciences (RNA) US $3.940B 0.00
PTC Therapeutics (PTCT) US $3.924B 0.00
Ultragenyx Pharmaceutical (RARE) US $3.659B 0.00
Akero Therapeutics (AKRO) US $3.610B 0.00
Arcellx (ACLX) US $3.609B 0.00
SpringWorks Therapeutics (SWTX) US $3.465B 0.00
Zai Lab (ZLAB) CN $3.431B 0.00
CRISPR Therapeutics AG (CRSP) CH $3.258B 0.00
Viking Therapeutics (VKTX) US $3.214B 0.00
Merus (MRUS) NL $3.144B 0.00
Scholar Rock Holding (SRRK) US $3.108B 0.00
Xenon Pharmaceuticals (XENE) CA $2.917B 0.00
Protagonist Therapeutics (PTGX) US $2.787B 10.71
Immunovant (IMVT) US $2.701B 0.00
MoonLake Immunotherapeutics (MLTX) CH $2.653B 0.00
HUTCHMED (China) (HCM) HK $2.580B 0.00
Apellis Pharmaceuticals (APLS) US $2.524B 0.00
Metsera (MTSR) US $2.454B 0.00
ACADIA Pharmaceuticals (ACAD) US $2.438B 21.75
Alvotech (ALVO) LU $2.394B 0.00
Denali Therapeutics (DNLI) US $2.333B 0.00
Biohaven (BHVN) US $2.291B 0.00
Kymera Therapeutics (KYMR) US $2.250B 0.00
Twist Bioscience (TWST) US $2.249B 0.00
ImmunityBio (IBRX) US $2.198B 0.00
Ascentage Pharma Group - (AAPG) CN $2.190B 0.00
Mirum Pharmaceuticals (MIRM) US $2.147B 0.00
Certara (CERT) US $2.146B 45.83
CG Oncology (CGON) US $2.114B 0.00
Tarsus Pharmaceuticals (TARS) US $2.113B 0.00
Ligand Pharmaceuticals (LGND) US $2.105B 0.00
Amicus Therapeutics (FOLD) US $2.057B 222.67
Kiniksa Pharmaceuticals (KNSA) GB $2.015B 0.00
NovoCure (NVCR) JE $2.001B 0.00
Beam Therapeutics (BEAM) US $1.994B 0.00
Belite Bio (BLTE) US $1.971B 0.00
Arrowhead Pharmaceuticals (ARWR) US $1.928B 0.00
Vericel (VCEL) US $1.901B 210.67
Janux Therapeutics (JANX) US $1.896B 0.00
Bavarian Nordic (BVNRY) DK $1.850B 13.03
Travere Therapeutics (TVTX) US $1.843B 0.00
IDEAYA Biosciences (IDYA) US $1.793B 0.00
Agios Pharmaceuticals (AGIO) US $1.792B 0.00
Apogee Therapeutics (APGE) US $1.759B 0.00
Edgewise Therapeutics (EWTX) US $1.748B 0.00
Arcutis Biotherapeutics (ARQT) US $1.746B 0.00
Disc Medicine (IRON) US $1.717B 0.00
Harmony Biosciences Holdings (HRMY) US $1.714B 11.90
Structure Therapeutics (GPCR) US $1.567B 0.00
ANI Pharmaceuticals (ANIP) US $1.539B 17.41
Mesoblast (MESO) AU $1.526B 0.00
Vera Therapeutics (VERA) US $1.514B 0.00
Immunocore Holdings (IMCR) GB $1.510B 0.00
MannKind (MNKD) US $1.504B 30.94
Dynavax Technologies (DVAX) US $1.405B 63.78
Celldex Therapeutics (CLDX) US $1.375B 0.00
Pacira BioSciences (PCRX) US $1.238B 11.63
WAVE Life Sciences (WVE) SG $1.223B 0.00
Liquidia Technologies (LQDA) US $1.195B 0.00
Syndax Pharmaceuticals (SNDX) US $1.189B 0.00
89BIO (ETNB) US $1.187B 0.00
GRAIL (GRAL) US $1.147B 0.00
Viridian Therapeutics (VRDN) US $1.121B 0.00
Adaptive Biotechnologies (ADPT) US $1.118B 0.00
Iovance Biotherapeutics (IOVA) US $1.112B 0.00
BGM Group (BGM) CN $1.099B 0.00
Novavax (NVAX) US $1.031B 0.00
Regencell Bioscience Holdings (RGC) HK $1.002B 0.00
Mineralys Therapeutics (MLYS) US $0.971B 0.00
NeoGenomics (NEO) US $0.934B 0.00
MiMedx (MDXG) US $0.933B 22.57
Pharvaris (PHVS) NL $0.933B 0.00
Arcus Biosciences (RCUS) US $0.913B 0.00
Geron (GERN) US $0.911B 0.00
Anbio Biotechnology (NNNN) DE $0.905B 0.00
Zymeworks (ZYME) US $0.896B 0.00
Intellia Therapeutics (NTLA) US $0.895B 0.00
Spyre Therapeutics (SYRE) US $0.884B 0.00
Gyre Therapeutics (GYRE) US $0.876B 116.75
Nurix Therapeutics (NRIX) US $0.851B 0.00
Vir Biotechnology (VIR) US $0.839B 0.00
Rocket Pharmaceuticals (RCKT) US $0.839B 0.00
UniQure (QURE) NL $0.822B 0.00
Bicara Therapeutics (BCAX) US $0.802B 0.00
LENZ Therapeutics (LENZ) US $0.795B 0.00
Anavex Life Sciences (AVXL) US $0.795B 0.00
Praxis Precision Medicines (PRAX) US $0.775B 0.00
Oculis Holding AG (OCS) CH $0.774B 0.00
Day One Biopharmaceuticals (DAWN) US $0.772B 0.00
Immunome (IMNM) US $0.771B 0.00
Nuvation Bio (NUVB) US $0.769B 0.00
CureVac (CVAC) DE $0.763B 4.15
AbCellera Biologics (ABCL) CA $0.743B 0.00
Replimune (REPL) US $0.742B 0.00
ArriVent BioPharma (AVBP) US $0.718B 0.00
Dianthus Therapeutics (DNTH) US $0.697B 0.00
Arbutus Biopharma (ABUS) US $0.691B 0.00
Trevi Therapeutics (TRVI) US $0.689B 0.00
Myriad Genetics (MYGN) US $0.657B 0.00
CorMedix Inc (CRMD) US $0.654B 0.00
Sinovac Biotech (SVA) CN $0.645B 0.00
AnaptysBio (ANAB) US $0.642B 0.00
Cogent Biosciences (COGT) US $0.641B 0.00
Bicycle Therapeutics (BCYC) GB $0.628B 0.00
Basilea Pharmaceutica AG (BPMUF) CH $0.626B 0.00
Pharming Group (PHGUF) NL $0.613B 0.00
Immatics (IMTX) DE $0.609B 35.79
Pharming Group (PHAR) NL $0.595B 0.00
Niagen Bioscience (NAGE) US $0.595B 189.00
Keros Therapeutics (KROS) US $0.592B 0.00
MeiraGTx Holdings (MGTX) US $0.580B 0.00
Sionna Therapeutics (SION) US $0.569B 0.00
GH Research (GHRS) IE $0.560B 0.00
Castle Biosciences (CSTL) US $0.557B 31.15
Tyra Biosciences (TYRA) US $0.556B 0.00
Fortrea Holdings (FTRE) US $0.550B 17.88
Stoke Therapeutics (STOK) US $0.539B 0.00
Arvinas (ARVN) US $0.528B 0.00
Urogen Pharma (URGN) US $0.526B 0.00
Opthea (OPT) AU $0.525B 0.00
Kura Oncology (KURA) US $0.524B 0.00
Cullinan Therapeutics (CGEM) US $0.503B 0.00
Mind Medicine (MindMed) (MNMD) US $0.497B 0.00
REGENXBIO (RGNX) US $0.493B 0.00
Zhengye Biotechnology Holding (ZYBT) CN $0.492B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) US $0.491B 0.00
Zenas BioPharma (ZBIO) US $0.484B 0.00
Upstream Bio (UPB) US $0.483B 0.00
Cytek Biosciences (CTKB) US $0.472B 0.00
Prothena (PRTA) IE $0.469B 0.00
Sage Therapeutics (SAGE) US $0.468B 0.00
Maze Therapeutics (MAZE) US $0.464B 0.00
Precigen (PGEN) US $0.458B 0.00
Eton Pharmaceuticals (ETON) US $0.455B 0.00
Abivax SA (ABVX) FR $0.438B 0.00
Northwest Biotherapeutics (NWBO) US $0.433B 0.00
Sana Biotechnology (SANA) US $0.428B 0.00
PureTech Health (PRTC) US $0.424B 0.00
Erasca (ERAS) US $0.422B 0.00
Rapport Therapeutics (RAPP) US $0.419B 0.00
Oxford BioMedica (OXBDF) GB $0.419B 0.00
Mereo BioPharma Group - (MREO) GB $0.413B 0.00
Celcuity (CELC) US $0.409B 0.00
Ginkgo Bioworks Holdings (DNA) US $0.404B 0.00
Oric Pharmaceuticals (ORIC) US $0.396B 0.00
Absci (ABSI) US $0.386B 0.00
Verastem (VSTM) US $0.383B 0.00
Kamada (KMDA) IL $0.378B 25.27
MBX Biosciences (MBX) US $0.377B 0.00
Allogene Therapeutics (ALLO) US $0.370B 0.00
Tectonic Therapeutic (TECX) US $0.367B 0.00
Olema Pharmaceuticals (OLMA) US $0.362B 0.00
Autolus Therapeutics (AUTL) GB $0.359B 0.00
Alpha Teknova (TKNO) US $0.353B 0.00
Checkpoint Therapeutics (CKPT) US $0.345B 0.00
Entrada Therapeutics (TRDA) US $0.343B 4.74
Arcturus Therapeutics Holdings (ARCT) US $0.339B 0.00
Benitec Biopharma (BNTC) US $0.338B 0.00
Abeona Therapeutics (ABEO) US $0.335B 0.00
Cartesian Therapeutics (RNAC) US $0.318B 0.00
Septerna (SEPN) US $0.318B 0.00
Terns Pharmaceuticals (TERN) US $0.311B 0.00
Aura Biosciences (AURA) US $0.305B 0.00
Monte Rosa Therapeutics (GLUE) US $0.301B 0.00
ATyr Pharma (ATYR) US $0.297B 0.00
MaxCyte (MXCT) US $0.297B 0.00
Astria Therapeutics (ATXS) US $0.291B 0.00
ITeos Therapeutics (ITOS) US $0.287B 0.00
Solid Biosciences (SLDB) US $0.283B 0.00
XOMA Royalty (XOMA) US $0.280B 0.00
Cidara Therapeutics (CDTX) US $0.273B 0.00
Design Therapeutics (DSGN) US $0.267B 0.00
Emergent Biosolutions (EBS) US $0.267B 0.00
Palvella Therapeutics (PVLA) US $0.266B 0.00
2seventy Bio (TSVT) US $0.265B 0.00
Monopar Therapeutics (MNPR) US $0.264B 0.00
Lexicon Pharmaceuticals (LXRX) US $0.262B 0.00
Vanda Pharmaceuticals (VNDA) US $0.262B 0.00
ACELYRIN, INC (SLRN) US $0.260B 0.00
Atea Pharmaceuticals (AVIR) US $0.256B 0.00
Lifecore Biomedical (LFCR) US $0.253B 0.00
Compass Therapeutics (CMPX) US $0.252B 0.00
Aardvark Therapeutics (AARD) US $0.246B 0.00
Prima BioMed (IMMP) AU $0.244B 0.00
Candel Therapeutics (CADL) US $0.241B 0.00
Gossamer Bio (GOSS) US $0.241B 0.00
Corvus Pharmaceuticals (CRVS) US $0.240B 0.00
Rezolute (RZLT) US $0.240B 0.00
Kodiak Sciences (KOD) US $0.237B 0.00
Fulcrum Therapeutics (FULC) US $0.236B 0.00
DBV Technologies S.A (DBVT) FR $0.236B 0.00
Phathom Pharmaceuticals (PHAT) US $0.234B 0.00
BioStem Technologies (BSEM) $0.233B 9.31
Third Harmonic Bio (THRD) US $0.233B 0.00
Foghorn Therapeutics (FHTX) US $0.231B 0.00
Prime Medicine (PRME) US $0.228B 0.00
Amarin (AMRN) IE $0.227B 0.00
Nuvectis Pharma (NVCT) US $0.227B 0.00
Neurogene (NGNE) US $0.220B 0.00
Humacyte (HUMA) US $0.219B 0.00
Bright Minds Biosciences (DRUG) US $0.216B 0.00
Ocugen (OCGN) US $0.216B 0.00
Adocia (ADOCY) FR $0.213B 0.00
Anika Therapeutics (ANIK) US $0.207B 0.00
GENFIT S.A (GNFT) FR $0.204B 0.00
Annexon (ANNX) US $0.204B 0.00
CARGO Therapeutics (CRGX) US $0.202B 0.00
Eledon Pharmaceuticals (ELDN) US $0.196B 0.00
Voyager Therapeutics (VYGR) US $0.196B 0.00
Codexis (CDXS) US $0.192B 0.00
EnGene Holdings (ENGN) CA $0.191B 0.00
Y-mAbs Therapeutics (YMAB) US $0.186B 0.00
Innate Pharma S.A (IPHA) FR $0.186B 0.00
Actuate Therapeutics (ACTU) US $0.186B 0.00
Inventiva S.A (IVA) FR $0.184B 0.00
ProQR Therapeutics (PRQR) NL $0.181B 0.00
Alumis (ALMS) US $0.181B 0.00
Cardiff Oncology (CRDF) US $0.180B 0.00
Semper Paratus Acquisition (TVGN) US $0.180B 0.00
Inhibrx Biosciences (INBX) US $0.178B 0.00
DiaMedica Therapeutics (DMAC) US $0.177B 0.00
INmune Bio (INMB) US $0.174B 0.00
TuHURA Biosciences (HURA) US $0.170B 0.00
Sangamo Therapeutics (SGMO) US $0.170B 0.00
Adherex Technologies (FENC) US $0.169B 0.00
AC Immune (ACIU) CH $0.168B 0.00
Galena Biopharma (SLS) US $0.153B 0.00
Puma Biotechnology (PBYI) US $0.153B 5.05
Tango Therapeutics (TNGX) US $0.152B 0.00
Molecular Partners AG (MOLN) CH $0.151B 0.00
Tiziana Life Sciences (TLSA) GB $0.151B 0.00
BioAge Labs (BIOA) US $0.148B 0.00
Nkarta (NKTX) US $0.145B 0.00
Fate Therapeutics (FATE) US $0.142B 0.00
ADC Therapeutics SA (ADCT) CH $0.142B 0.00
Eupraxia Pharmaceuticals (EPRX) CA $0.138B 0.00
Compugen (CGEN) IL $0.136B 0.00
Editas Medicine (EDIT) US $0.136B 0.00
Theratechnologies (THTX) CA $0.134B 0.00
Greenwich LifeSciences (GLSI) US $0.132B 0.00
ScPharmaceuticals (SCPH) US $0.127B 0.00
Vigil Neuroscience (VIGL) US $0.126B 0.00
Neumora Therapeutics (NMRA) US $0.125B 0.00
InflaRx (IFRX) DE $0.124B 0.00
Alector (ALEC) US $0.122B 0.00
Seer (SEER) US $0.122B 0.00
Coherus BioSciences (CHRS) US $0.122B 0.00
Rapt Therapeutics (RAPT) US $0.121B 0.00
Sagimet Biosciences (SGMT) US $0.121B 0.00
C4 Therapeutics (CCCC) US $0.116B 0.00
Immunic (IMUX) US $0.112B 0.00
BioHarvest Sciences (BHST) CA $0.109B 0.00
Orchestra BioMed Holdings (OBIO) US $0.105B 0.00
Coya Therapeutics (COYA) US $0.105B 0.00
Zentalis Pharmaceuticals (ZNTL) US $0.104B 0.00
Contineum Therapeutics (CTNM) US $0.103B 0.00
Entera Bio (ENTX) IL $0.101B 0.00
Zura Bio (ZURA) US $0.101B 0.00
Cuprina Holdings (Cayman) (CUPR) SG $0.100B 0.00
Pliant Therapeutics (PLRX) US $0.099B 0.00
Ventyx Biosciences (VTYX) US $0.098B 0.00
HilleVax (HLVX) US $0.097B 0.00
Black Diamond Therapeutics (BDTX) US $0.096B 0.00
Kyverna Therapeutics (KYTX) US $0.096B 0.00
Alpha Cognition (ACOG) CA $0.096B 0.00
EXoZymes (EXOZ) US $0.092B 0.00
CervoMed (CRVO) US $0.092B 0.00
Genelux (GNLX) US $0.092B 0.00
Sutro Biopharma (STRO) US $0.090B 0.00
Elutia (ELUT) US $0.090B 0.00
ANIXA BIOSCIENCES INC (ANIX) US $0.090B 0.00
Cellectis S.A (CLLS) FR $0.090B 0.00
XBiotech (XBIT) US $0.089B 0.00
TScan Therapeutics (TCRX) US $0.088B 0.00
Nautilus Biotechnology (NAUT) US $0.086B 0.00
Climb Bio (CLYM) US $0.085B 0.00
Senti Biosciences (SNTI) US $0.085B 0.00
Seres Therapeutics (MCRB) US $0.083B 0.00
Instil Bio (TIL) US $0.083B 0.00
Vor Biopharma (VOR) $0.083B 0.00
Jasper Therapeutics (JSPR) US $0.081B 0.00
IGM Biosciences (IGMS) US $0.080B 0.00
Elicio Therapeutics (ELTX) US $0.080B 0.00
Inozyme Pharma (INZY) US $0.078B 0.00
Biomea Fusion (BMEA) US $0.076B 0.00
Caribou Biosciences (CRBU) US $0.075B 0.00
Adagene (ADAG) CN $0.074B 0.00
Adlai Nortye (ANL) KY $0.074B 0.00
Invivyd (IVVD) US $0.073B 0.00
Genenta Science S.p.A (GNTA) IT $0.073B 0.00
BeyondSpring (BYSI) US $0.072B 0.00
MediciNova (MNOV) US $0.072B 0.00
I-Mab (IMAB) US $0.071B 0.00
Adaptimmune Therapeutics (ADAP) GB $0.071B 0.00
Milestone Pharmaceuticals (MIST) CA $0.071B 0.00
Adverum Biotechnologies (ADVM) US $0.070B 0.00
Inovio Pharmaceuticals (INO) US $0.069B 0.00
ZIVO Bioscience (ZIVO) US $0.069B 0.00
VistaGen Therapeutics (VTGN) US $0.068B 0.00
IO Biotech (IOBT) DK $0.067B 0.00
Alto Neuroscience (ANRO) US $0.066B 0.00
Clearside Biomedical (CLSD) US $0.066B 0.00
VTv Therapeutics (VTVT) US $0.065B 0.00
Acumen Pharmaceuticals (ABOS) US $0.065B 0.00
Prenetics Global (PRE) HK $0.064B 0.00
Citius Oncology (CTOR) US $0.064B 0.00
Cabaletta Bio (CABA) US $0.063B 0.00
Exicure (XCUR) US $0.063B 0.00
Skye Bioscience (SKYE) US $0.063B 0.00
Rani Therapeutics Holdings (RANI) US $0.062B 0.00
CytomX Therapeutics (CTMX) US $0.061B 1.99
Achilles Therapeutics (ACHL) GB $0.061B 0.00
PDS Biotechnology (PDSB) US $0.061B 0.00
Agenus (AGEN) US $0.061B 0.00
Repare Therapeutics (RPTX) CA $0.060B 0.00
Akoya Biosciences (AKYA) US $0.060B 0.00
Precision BioSciences (DTIL) US $0.060B 0.00
Ikena Oncology (IKNA) US $0.059B 0.00
Applied Therapeutics (APLT) US $0.059B 0.00
Medicus Pharma (MDCX) US $0.058B 0.00
Artiva Biotherapeutics (ARTV) US $0.058B 0.00
Immix Biopharma (IMMX) US $0.057B 0.00
Earth Science Tech (ETST) US $0.053B 0.00
OKYO Pharma (OKYO) $0.053B 0.00
Adicet Bio (ACET) US $0.052B 0.00
Fortress Biotech (FBIO) US $0.052B 0.00
Shattuck Labs (STTK) US $0.052B 0.00
Biodexa Pharmaceuticals (BDRX) GB $0.052B 0.00
Cyclacel Pharmaceuticals (CYCC) US $0.051B 0.00
Oncobiologics (OTLK) US $0.050B 0.00
Mersana Therapeutics (MRSN) US $0.050B 0.00
Renovaro (RENB) US $0.049B 0.00
Anebulo Pharmaceuticals (ANEB) US $0.048B 0.00
PepGen (PEPG) US $0.048B 0.00
Quince Therapeutics (QNCX) US $0.048B 0.00
Oncolytics Biotech (ONCY) CA $0.048B 0.00
Forte Biosciences (FBRX) US $0.047B 0.00
Cue Biopharma (CUE) US $0.046B 0.00
Immuneering (IMRX) US $0.046B 0.00
Connect Biopharma Holdings (CNTB) US $0.045B 0.00
Atara Biotherapeutics (ATRA) US $0.045B 0.00
Tenaya Therapeutics (TNYA) US $0.045B 0.00
Barinthus Biotherapeutics (BRNS) GB $0.044B 0.00
Kronos Bio (KRON) US $0.044B 0.00
Opus Genetics (IRD) US $0.043B 0.00
Advanced Biomed (ADVB) US $0.041B 0.00
Whitehawk Therapeutics (WHWK) US $0.041B 0.00
Estrella Immunopharma (ESLA) US $0.041B 0.00
Bluebird Bio (BLUE) US $0.040B 0.00
TELA Bio (TELA) US $0.040B 0.00
Xilio Therapeutics (XLO) US $0.039B 0.00
Werewolf Therapeutics (HOWL) US $0.039B 0.00
Lantern Pharma (LTRN) US $0.039B 0.00
FibroBiologics (FBLG) US $0.039B 0.00
Tvardi Therapeutics (TVRD) US $0.039B 0.00
CAMP4 Therapeutics (CAMP) US $0.038B 0.00
Celularity (CELU) US $0.037B 0.00
AN2 Therapeutics (ANTX) US $0.037B 0.00
Akari Therapeutics (AKTX) GB $0.037B 0.00
Aligos Therapeutics (ALGS) US $0.037B 0.00
Spero Therapeutics (SPRO) US $0.037B 0.00
Dyadic (DYAI) US $0.036B 0.00
RenovoRx (RNXT) US $0.036B 0.00
Rein Therapeutics (RNTX) US $0.036B 0.00
Boundless Bio (BOLD) US $0.036B 0.00
Scilex Holding (SCLX) US $0.035B 0.00
OnKure Therapeutics (OKUR) US $0.034B 0.00
Pluri (PLUR) IL $0.033B 0.00
LAVA Therapeutics (LVTX) NL $0.033B 0.00
Kezar Life Sciences (KZR) US $0.032B 0.00
Cadrenal Therapeutics (CVKD) US $0.032B 0.00
Femasys (FEMY) US $0.032B 0.00
Alterity Therapeutics - (ATHE) AU $0.031B 0.00
Radiopharm Theranostics - (RADX) AU $0.030B 0.00
Kalaris Therapeutics (KLRS) US $0.030B 0.00
Allakos (ALLK) US $0.029B 0.00
Generation Bio (GBIO) US $0.029B 0.00
MiNK Therapeutics (INKT) US $0.029B 0.00
BioAtla (BCAB) US $0.029B 0.00
Coeptis Therapeutics Holdings (COEP) US $0.028B 0.00
Cognition Therapeutics (CGTX) US $0.028B 0.00
ALX Oncology Holdings (ALXO) US $0.028B 0.00
Grace Therapeutics (GRCE) CA $0.027B 0.00
Clene (CLNN) US $0.027B 0.00
Dare Bioscience (DARE) US $0.026B 0.00
CollPlant Biotechnologies (CLGN) IL $0.025B 0.00
KALA BIO (KALA) US $0.024B 0.00
Tenax Therapeutics (TENX) US $0.024B 0.00
Longeveron (LGVN) US $0.023B 0.00
Ovid Therapeutics (OVID) US $0.022B 0.00
Annovis Bio (ANVS) US $0.022B 0.00
X4 Pharmaceuticals (XFOR) US $0.022B 0.00
CalciMedica (CALC) US $0.022B 0.00
Lexaria Bioscience (LEXX) CA $0.022B 0.00
Promis Neurosciences (PMN) CA $0.021B 0.00
Curis (CRIS) US $0.021B 0.00
Passage Bio (PASG) US $0.021B 0.00
Lisata Therapeutics (LSTA) US $0.021B 0.00
Cardio Diagnostics Holdings (CDIO) US $0.021B 0.00
Elevation Oncology (ELEV) US $0.020B 0.00
Allarity Therapeutics (ALLR) US $0.020B 0.00
Chemomab Therapeutics (CMMB) IL $0.020B 0.00
MIRA Pharmaceuticals (MIRA) US $0.019B 0.00
Q32 Bio (QTTB) US $0.019B 0.00
UNITY Biotechnology (UBX) US $0.019B 0.00
Beyond Air (XAIR) US $0.018B 0.00
Quantum Biopharma (QNTM) CA $0.018B 0.00
Affimed (AFMD) DE $0.018B 0.00
Aspire Biopharma Holdings (ASBP) US $0.018B 0.00
Gelteq (GELS) AU $0.018B 0.00
ABVC BioPharma (ABVC) US $0.017B 0.00
Leap Therapeutics (LPTX) US $0.017B 0.00
Cingulate (CING) US $0.017B 0.00
Edesa Biotech (EDSA) CA $0.017B 0.00
HOOKIPA Pharma (HOOK) US $0.016B 0.00
SAB Biotherapeutics (SABS) US $0.016B 0.00
BRIACELL THERAP (BCTX) CA $0.015B 0.00
Equillium (EQ) US $0.015B 0.00
BioCardia (BCDA) US $0.015B 0.00
NeuroSense Therapeutics (NRSN) IL $0.014B 0.00
Moleculin Biotech (MBRX) US $0.014B 0.00
IN8bio (INAB) US $0.014B 0.00
GeoVax Labs (GOVX) US $0.014B 0.00
Bolt Biotherapeutics (BOLT) US $0.013B 0.00
NextCure (NXTC) US $0.013B 0.00
Biorestorative Therapies (BRTX) US $0.013B 0.00
Synlogic (SYBX) US $0.013B 0.00
Rallybio (RLYB) US $0.013B 0.00
Bionano Genomics (BNGO) US $0.012B 0.00
Imunon (IMNN) US $0.012B 0.00
COSCIENS Biopharma (CSCI) CA $0.012B 0.00
Hoth Therapeutics (HOTH) US $0.012B 0.00
LakeShore Biopharma (LSB) CN $0.012B 0.00
Abpro Holdings (ABP) US $0.011B 0.00
Portage Biotech (PRTG) $0.011B 0.00
Athira Pharma (ATHA) US $0.011B 0.00
Cyclerion Therapeutics (CYCN) US $0.011B 0.00
IMMURON (IMRN) AU $0.011B 0.00
Dogwood Therapeutics (DWTX) US $0.010B 0.00
IBio (IBIO) US $0.010B 0.00
Sensei Biotherapeutics (SNSE) US $0.010B 0.00
Aprea Therapeutics (APRE) US $0.010B 0.00
BioXcel Therapeutics (BTAI) US $0.010B 0.00
Acurx Pharmaceuticals (ACXP) US $0.009B 0.00
Neuphoria Therapeutics (NEUP) AU $0.009B 0.00
Creative Medical Technology Holdings (CELZ) US $0.009B 0.00
HCW Biologics (HCWB) US $0.009B 0.00
Silexion Therapeutics Corp (SLXN) IL $0.009B 0.00
BioAffinity Technologies (BIAF) US $0.009B 0.00
Intensity Therapeutics (INTS) US $0.009B 0.00
Aytu BioPharma (AYTU) US $0.008B 0.00
Turnstone Biologics (TSBX) US $0.008B 0.00
Brainstorm Cell Therapeutics (BCLI) US $0.008B 0.00
Apollomics (APLM) US $0.007B 0.00
Mainz Biomed (MYNZ) DE $0.007B 0.00
180 Life Sciences (ATNF) US $0.007B 0.00
GENPREX (GNPX) US $0.007B 0.00
MetaVia (MTVA) US $0.007B 0.00
Biofrontera (BFRI) US $0.007B 0.00
Lipella Pharmaceuticals (LIPO) US $0.006B 0.00
GT Biopharma (GTBP) US $0.006B 0.00
Evogene (EVGN) IL $0.006B 0.00
Avalon GloboCare (ALBT) US $0.006B 0.00
Adial Pharmaceuticals (ADIL) US $0.005B 0.00
Onconetix (ONCO) US $0.005B 0.00
Dermata Therapeutics (DRMA) US $0.005B 0.00
Arcadia Biosciences (RKDA) US $0.005B 0.00
Ensysce Biosciences (ENSC) US $0.005B 0.00
Soligenix (SNGX) US $0.005B 0.00
Alzamend Neuro (ALZN) US $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) US $0.004B 0.00
Pasithea Therapeutics (KTTA) US $0.004B 0.00
Galecto (GLTO) DK $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) US $0.004B 0.00
Novogen (KZIA) AU $0.004B 0.00
Sunshine Biopharma (SBFM) US $0.004B 0.00
Organovo Holdings (VIVS) US $0.004B 0.00
Mustang Bio (MBIO) US $0.004B 0.00
Windtree Therapeutics (WINT) US $0.004B 0.00
Titan Pharmaceuticals (TTNP) US $0.004B 0.00
Silo Pharma (SILO) US $0.004B 0.00
Palisade Bio (PALI) US $0.003B 0.00
Tharimmune (THAR) US $0.003B 0.00
Synaptogenix (SNPX) US $0.003B 0.00
Artelo Biosciences (ARTL) US $0.003B 0.00
Eyenovia (EYEN) US $0.003B 0.00
Hepion Pharmaceuticals (HEPA) US $0.003B 0.00
Virax Biolabs Group (VRAX) GB $0.003B 0.00
Enveric Biosciences (ENVB) US $0.003B 0.00
Purple Biotech (PPBT) IL $0.003B 0.00
CNS Pharmaceuticals (CNSP) US $0.003B 0.00
NuCana (NCNA) GB $0.003B 0.00
Aptevo Therapeutics (APVO) US $0.003B 0.00
Revelation Biosciences (REVB) US $0.003B 0.00
Scinai Immunotherapeutics (SCNI) IL $0.003B 0.00
AquaBounty Technologies (AQB) US $0.003B 0.00
Bone Biologics (BBLG) US $0.002B 0.00
Evaxion Biotech (EVAX) DK $0.002B 0.00
Atrinsic (PTIX) US $0.002B 0.00
Psyence Biomedical (PBM) CA $0.002B 0.00
Entero Therapeutics (ENTO) US $0.002B 0.00
ZyVersa Therapeutics (ZVSA) US $0.002B 0.00
Polyrizon (PLRZ) IL $0.001B 0.00
GRI Bio (GRI) US $0.001B 0.00
Capstone Therapeutics (CAPS) US $0.000B 0.00
TFF Pharmaceuticals (TFFP) US $0.000B 0.00
Aceragen (ACGN) US $0.000B 0.00
ARAVIVE, INC (ARAV) US $0.000B 0.00
Clovis Oncology (CLVSQ) US $0.000B 0.00
Cocrystal Pharma (COCP) US $0.000B 0.00
Celyad SA (CYAD) BE $0.000B 0.00
CytoMed Therapeutics (GDTC) SG $0.000B 0.00
Galapagos (GLPG) BE $0.000B 0.00
Motif Bio Plc (MTFB) GB $0.000B 0.00
PDL BioPharma (PDLI) US $0.000B 0.00
Pulmatrix (PULM) US $0.000B 0.00
VectivBio Holding AG (VECT) CH $0.000B 0.00